Data from Pharmawand - Curated by EPG Health - Date added 28 November 2018
Mesa Biotech announced that it received 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the FDA for its Accula RSV test. The respiratory syncytial virus or RSV test cassette is cleared for diagnosing both children and adult populations.
The Accula RSV test is the second molecular POC diagnostic on the Accula platform to receive FDA clearance and CLIA waiver, following the company's Flu A/Flu B test, cleared earlier this year. The Accula molecular test system provides the superior sensitivity, specificity and information content of laboratory-based PCR testing, while offering the simplicity, convenience and procedural familiarity of traditional POC rapid immunoassays, with its palm-sized, reusable dock and disposable test cassettes.
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Atopic Dermatitis
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
Cystic Fibrosis Knowledge Centre
View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines.
Chronic Obstructive Pulmonary Disease (COPD)
View highlights from recent congresses presented in new expert videos with leading physicians.
+ 7 more
Allergic Rhinitis
Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.
+ 4 more
EADV 2018 Highlights
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
Chronic Spontaneous Urticaria (CSU)
Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.
+ 7 more
Related Content
AstraZeneca to divest US rights to Synagis to SOBI.
AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection...
Added 3 months ago
Suptavumab (REGN 2222) fails Phase III trial to prevent medically-attended RSV infections in infants.- Regeneron.
Regeneron Pharmaceuticals, Inc.announced that a Phase III study evaluating suptavumab (REGN 2222), an antibody to respiratory syncytial virus (RSV), did...
Added 1 year ago
NxTAG Respiratory Pathogen Panel diagnostic filed with FDA for 510(k) approval- Luminex Corp
Luminex Corporation announced that it has submitted a 510(k) application to the FDA for the company's NxTAG Respiratory Pathogen Panel....
Added 3 years ago
FDA grants accelerated approval to Arikayce to treat mycobacterium avium complex lung disease.-Insmed
Insmed Incorporated announced that the FDA has granted accelerated approval of Arikayce (amikacin liposome inhalation suspension) for the treatment of...
Added 4 months ago
Phase III CONVERT study of amikacin liposome suspension in nontuberculous mycobacterial lung disease published in AJRCCM.- Insmed.
Insmed Incorporated announced that data from the pivotal Phase III CONVERT study evaluating the safety and efficacy of ALIS (amikacin...
Added 5 months ago
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)
Background: Community-acquired bacterial pneumonia (CABP) is a leading cause of morbidity and mortality, and treatment recommendations, each with specific limitations,...
Added 3 years ago
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
BACKGROUND: Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in adults 65...
Added 3 years ago
Nintedanib for the treatment of idiopathic pulmonary fibrosis.
Areas covered: Herein, the authors review the working mechanisms of nintedanib, its pharmacological profile, and its efficacy and safety for patients with IPF.
Added 8 months ago
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. (ACCORD)
The purpose of this study is to determine whether Ingavirin ® dosed 30 mg daily is effective and safe in...
Added 4 years ago
A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections
The purpose of the study is to assess viral kinetics and clinical symptoms kinetics in pediatric patients hospitalized with Respiratory...
Added 5 years ago
A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From Birth up to 2 Years of Age
The purpose of this study is to assess the incidence and associated healthcare utilization of RSV-associated, suspected LRTI in a...
Added 6 years ago
Work of Breathing in Nasal CPAP Versus High Flow Nasal Prong in Infants With Severe Acute Bronchiolitis
Nasal continuous positive airway pressure (nCPAP), widely used in neonatal intensive care is also more and more used in infants...
Added 6 years ago
The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children
The purpose of this study is to study the effect of a probiotic on protection against upper respiratory tract infections...
Added 6 years ago
Bronchiolitis in children: diagnosis and management
This guideline covers diagnosing and managing bronchiolitis in children. It aims to help healthcare professionals diagnose bronchiolitis and identify if children should be cared for at home or in hospital.
Added 3 years ago
Guidelines for the management of adult lower respiratory tract infections
It provides evidence-based recommendations for the most common management questions occurring in routine clinical practice in the management of adult patients with LRTI.
Added 7 years ago
Comments
You will need to login, to leave a comment.
epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.